This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Demographic, clinical, and diagnostic data, as well as follow-up outcomes, were reviewed. Patients with RP-HCM showed the poorest outcomes, with a follow-up mortality rate of 42.86%. ConclusionsThis study underscores the importance of early diagnosis, genetic testing, and integrated management in pediatric cardiomyopathies.
12, 2024 Physicians have a new treatment option for many of the sickest pediatric patients with heart failure andcardiogenic shock. has partnered with the Advanced Cardiac Therapies Improving Outcomes Network (ACTION) 1 to provide the real-world data necessary to support on-label use of Impella 5.5
The Transplant Company recently announced that AlloSureis now commercially available for pediatric heart transplant patients of all ages and patients who have received a simultaneous pancreas-kidney (SPK) transplant. 1 "The availability of AlloSure dd-cfDNA for all pediatric heart transplant patients is a major development.
In light of the limited availability of donor organs, particularly in Europe, the number of children requiring ventricular assist device support is rising at an unavoidable rate.MethodsWe performed a retrospective cohort study of patients who underwent a single and primary pediatric heart transplantation.
Lisa Swanson, MD, discusses the recent advancements in pediatric dermatology and emphasizes the importance of correctly diagnosing conditions to improve patient outcomes.
Getty Images milla1cf Wed, 02/21/2024 - 19:10 February 21, 2024 — Ochsner Children's Hospital , ranked among the top hospitals in the nation for pediatric cardiology and congenital heart surgery, is raising awareness of the need for more pediatric-specific heart devices. Yet, research and innovation in this field has not kept pace.
New data from the UNOS database presented at NASPGHAN 2024 details characteristics and outcomes of pediatric liver transplant patients receiving machine perfused organs.
THE TEXAS HEART INSTITUTE 2024 milla1cf Tue, 02/13/2024 - 17:56 February 13, 2024 — Pediatric heart transplantation has long been hailed as a life-saving intervention for children suffering from end-stage heart failure. Our approach offers an unprecedented level of detail," said Dr. Martin. "We
Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. Lantheus announced that the U.S.
There is increasing recognition that nearly all cancer treatments pose some short- or long-term risk for development of cardiovascular disease and that pediatric patients with cancer may be especially vulnerable to cardiovascular disease because of young age at treatment and expected long life span afterward.
Cardiac catheterizations and interventions can be performed safely on pediatric patients on extracorporeal membrane oxygenation (ECMO); however, this patient population has an increased risk of adverse events vs. patients not on ECMO, according to a first-of-its-kind multicenter review.
This review synthesizes current evidence on pediatric VVS, focusing on advances in diagnosis, management, and long-term outcomes. Future research should focus on developing predictive models for recurrence risk and exploring personalized treatment approaches to improve outcomes.
Pediatric heart transplantation has long been hailed as a life-saving intervention for children suffering from end-stage heart failure. While the procedure offers hope, the long-term outcomes for these young patients remain suboptimal due to allograft rejection and graft failure.
Casey Schlacher discusses the FDA approval of the new weight-based oral solution, RINVOQ LQ (upadacitinib), for treating pediatric patients with arthritis, highlighting its importance for improving patient outcomes and quality of life.
(MedPage Today) -- Beneficial pediatric obesity treatment response was associated with a reduced risk of obesity-related events in young adults, a nationwide prospective cohort study in Sweden showed. Compared with poor response, good response.
Olivia Ostrow, Pediatric Emergency Physician at Hospital for Sick Children, Assistant professor at the University of Toronto and a Medical Safety Leader with an academic focus in quality improvement, discusses a case that exemplifies how indiscriminate work up of pediatric UTI can lead to over-testing, over-treating and even worse outcomes.
Getty Images milla1cf Tue, 01/30/2024 - 20:08 January 30, 2024 — A study of pediatric heart surgery centers across the United States has demonstrated that, when it comes to successful surgery, it’s not just the size of the program that matters in determining quality outcomes. However, a team led by D.
Among pediatric patients undergoing orthotopic heart transplantation (OHT), 1-12% are reported to need a permanent pacemaker (PPM).1 1 There are limited studies on the outcomes of PPM placement, and the role of implantable cardioverter-defibrillator (ICD) in pediatric OHT remains unclear.
The impact of chest compression (CC) pause duration on survival outcomes in pediatric in-hospital cardiac arrests remains unclear, despite the American Heart Association’s recommendation to limit pauses to less than 10 seconds for children without solid evidence. years, 43% of whom were female, and 13% had a shockable rhythm.
Prevalence and scores for depression and anxiety were ascertained children with AIS and compared with general pediatric population scores. In AIS patients, mean scores for mood, anxiety and somatization were higher compared to the general pediatric population. years [0 13.8
citizen, national, or permanent resident; meet educational and credential requirements; and either be employed or begin training as a pediatric specialist at a PSLRP-approved site serving a medically underserved area or population. This program invests in current and future pediatric cardiothoracic surgeons to meet the growing demand.
At their first appointment, the family met with a complete team of fetal and pediatric heart specialists, maternal fetal medicine experts, genetic counselors and other doctors to review and confirm Zanes diagnosis. Consistently ranked in the top 10 pediatric cardiology programs by U.S.
Introduction:Previous single-center studies have found a higher prevalence of mental health disorders in parents of children with pediatric stroke compared to general population prevalences of 5% with depression and 6% with anxiety. Social determinants of health may influence mental health outcomes.
This investigation describes the prevalence, risk factors, and outcomes associated with FVH in pediatric arterial ischemic stroke (AIS).METHODS:Retrospective Wilcoxon rank-sum test evaluated the association of FVH score with the presence of LVO and poor outcome. interquartile range, 37) in those with LVO (P<0.0001).
Most studies of VT RFA in ARVC included adult patients shown to be safe and reduces VA burden and ICD therapies while data on safety and efficacy in pediatric age group is lacking.
Pediatric ICD implantation presents unique challenges, including higher failure rates of transvenous ICD (TV-ICD) leads compared to adults. Data on S-ICD outcomes in the pediatric population are limited. The subcutaneous ICD (S-ICD) provides an alternative option.
BackgroundCryoablation for pediatric atrioventricular nodal reentry tachycardia (AVNRT) is favored for reducing conduction system injury compared to radiofrequency (RF) ablation. Currently, 3D EAM systems offer precise and efficient guidance, improving safety and outcomes.
Arrhythmias in pediatric heart transplant patients have historically raised concerns for acute rejection, often prompting invasive evaluations and empiric treatment. Despite this, the association of post-transplant arrhythmias with adverse outcomes remains understudied.
In children with septic shock, norepinephrine as the first vasoactive agent was linked to lower 30-day mortality than epinephrine, with no renal outcome difference.
Background:Studies describing outcomes of subarachnoid hemorrhage (SAH) in children are sparse. Conclusion:Six of ten pediatric patients with SAH are discharged with excellent outcome with a 10% index hospitalization mortality. Stroke, Volume 55, Issue Suppl_1 , Page ATP19-ATP19, February 1, 2024.
IntroductionDue to the relative rarity of unruptured intracranial aneurysms (UIA) in the pediatric population, evidence regarding treatment modalities and clinical outcomes remains limited. vs. 91.1%, p = 0.006), shorter durations of hospital stay (4.6 vs. 91.1%, p = 0.006), shorter durations of hospital stay (4.6
Introduction:Recent studies in adults have reported an association between neighborhood-level deprivation, infarct volume and outcome. However, this is yet to be investigated in pediatric arterial ischemic stroke (AIS). Conclusion:Our study findings confirm the relationship between infarct volume and pediatric AIS outcomes.
Wolff-Parkinson-White (WPW) exhibits variable presentations and outcomes in pediatric populations. Understanding clinical and EP characteristics is critical for optimizing risk stratification and management.
This review highlights disparities among patients of color in terms of atopic dermatitis prevalence, management, and outcomes in the post-COVID-19 world.
But across centers, studies have shown that there can be significant variations in outcomes for these patients. Every year, more than 40,000 patients in the U.S. undergo congenital heart surgery.
Non-sustained ventricular tachycardia (NSVT) is a marker for worse outcomes in adults but its significance in otherwise healthy pediatric populations remains unclear. The Zio patch, an ambulatory event monitor worn for up to 14 days, is used to investigate potential arrhythmias.
Non-sustained ventricular tachycardia (NSVT) is a marker for worse outcomes in adults but its significance in otherwise healthy pediatric populations remains unclear. The Zio patch, an ambulatory event monitor worn for up to 14 days, is used to investigate potential arrhythmias.
A study found omalizumab enables faster, safer desensitization in children with food allergies, improving oral immunotherapy outcomes and reducing reactions.
Does hospital median cardiopulmonary resuscitation (CPR) duration in patients without return of circulation (ROC) predict survival among hospitalized children?
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
52 
Let's personalize your content